Log In
BCIQ
Print this Print this
 

WEB Aneurysm Embolization System

  Manage Alerts
Collapse Summary General Information
Company Sequent Medical Inc.
DescriptionIntrasaccular flow disruptor comprised of dense mesh Nitinol wires
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPivotal
Standard IndicationStroke
Indication DetailsTreat intracranial aneurysms
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$380.0M

$280.0M

$100.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/14/2016

$380.0M

$280.0M

$100.0M

Get a free BioCentury trial today